Medicare Part D in 2026:
What Prescribers Need to Know

Recorded Wednesday, August 12th

 Duration 60 minutes

Description

Changes to Medicare rules, plan incentives, and financial responsibility can directly impact the prescribing of treatments for your patients. Part D plans can make it decidedly easier or harder to prescribe one medication versus another, and these practices can sometimes be grounded in financial considerations rather than clinical. Join us to learn how Part D plans may be responding to changes in Medicare, what you or your staff can do to minimize disruptions and delays if a Part D plan denies or delays coverage for the CLL treatment best suited to your patient. We will share practical steps you can take to navigate barriers and alert advocacy organizations like ours to take on the new and ongoing systemic barriers you and your office face.

Please find the virtual event transcript for the on-demand event here.

Speakers

Speaker:
Saira Sultan - CLL Society

Saira Sultan, JD
President & CEO
Connect 4 Strategies
Director of Government Affairs & Public Policy
CLL Society

Speaker:
kay-scanlan

Kay Scanlan, JD
Principal
Consilium Strategies

Find CLL Society on Social Media

Follow CLL Society on Facebook @CLLSociety as well as other social media platforms below.

This program was created in partnership with

ACCC Logo
© 2026. The Association of Cancer Care Centers (ACCC) provides education and advocacy for the cancer care community. Access additional resources at accc-cancer.org/CLL.
 
This program was made possible by generous donors and grant support from Astra Zeneca and BeOne.
AstraZeneca Logo
BeOne logo